Xbrane Biopharma AB (publ) announced the appointment of Anette Lindqvist as Chief Financial Officer & Head of Investor Relations effective from January 1, 2021. Anette brings extensive experience from Senior Finance & Business Roles in the Life Science sector such as AstraZeneca, Mölnlycke Healthcare and Getinge Infection Control. Her education includes studies at Gothenburg School of Economics, tax & auditing as well as leadership and business development. Anette replaces Margareta Hagman, interim CFO, whom will be available during a transition period.